Our Leadership

Our executive team consists of individuals with deep clinical research experience, as well as those with domain expertise in healthcare and enterprise software. This rare combination of technical and industry knowledge gives us the necessary insight to design simple and effective solutions for clinical research. It positions us as a valuable resource to the Clinical Trials Pharma industry.

Trevor Coughlan

CEO – Co Founder

28 years operations leader with Hi-Tech Manufacturing &, clinical operations. Designed the OTT Platform after a successful pilot. Master Black Belt in Lean systems and Technology.

Kishore Manoharan

CTO – Co Founder

20+ years Highly skilled Solution Architect. Built the On-Time Trials Platform that is ready to use.

Billy Taaffe

Chief Strategy Officer

Over 40 years of experience across the cinical research space. Instrumental in the trajectory of the growth of ICON where he spent 18 years and held the position of President and Chief Executive Officer, North America.

Sean McCluskey

Chief Commercial Officer

28 years Leadership in US Health Care / Si Valley, Payers & Disruptive Innovators.

Tim Van Meter

Medical Advisor

20+ years leading teams in genomics, neuroscience and cancer research. PhD Neuropathology and has spearheaded international research consortia.

Kevin Futch

Finance Advisor

20+ years of finance/controllership across multiple industries. Co-founder/CFO for software startup and graduate of GE Financial Leadership program with an MBA from University of Southern California.

Nikhil Parekh

Innovation Advisor

An enterprise and a visionary leader with 35+ years of experience in discovery, development, in-licensing and commercialization of innovative consumer health care and prescription pharmaceutical products.

Stu Schulman

Commercial Advisor

20+ years of pharmaceutical and healthcare sales, account management, and executive leadership. Extensive experience serving in progressive leadership roles in complex, matrixed organizations, developing go-to-market strategies and exploring new revenue growth opportunities.

Eric Hamborg